Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
S L Rowland-Jones, … , A J McMichael, F A Plummer
S L Rowland-Jones, … , A J McMichael, F A Plummer
Published November 1, 1998
Citation Information: J Clin Invest. 1998;102(9):1758-1765. https://doi.org/10.1172/JCI4314.
View: Text | PDF
Research Article Article has an altmetric score of 23

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.

  • Text
  • PDF
Abstract

Many people who remain persistently seronegative despite frequent HIV exposure have HIV-specific immune responses. The study of these may provide information about mechanisms of natural protective immunity to HIV-1. We describe the specificity of cytotoxic T lymphocyte responses to HIV in seronegative prostitutes in Nairobi who are apparently resistant to HIV infection. These women have had frequent exposure to a range of African HIV-1 variants, primarily clades A, C, and D, for up to 12 yr without becoming infected. Nearly half of them have CTL directed towards epitopes previously defined for B clade virus, which are largely conserved in the A and D clade sequences. Stronger responses are frequently elicited using the A or D clade version of an epitope to stimulate CTL, suggesting that they were originally primed by exposure to these virus strains. CTL responses have been defined to novel epitopes presented by HLA class I molecules associated with resistance to infection in the cohort, HLA-A*6802 and HLA-B18. Estimates using a modified interferon-gamma Elispot assay indicate a circulating frequency of CTL to individual epitopes of between 1:3,200 and 1:50,000. Thus, HIV-specific immune responses-particularly cross-clade CTL activity- may be responsible for protection against persistent HIV infection in these African women.

Authors

S L Rowland-Jones, T Dong, K R Fowke, J Kimani, P Krausa, H Newell, T Blanchard, K Ariyoshi, J Oyugi, E Ngugi, J Bwayo, K S MacDonald, A J McMichael, F A Plummer

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1997 1994 Total
Citations: 2 3 2 2 4 1 3 2 7 8 10 12 8 8 11 13 15 17 25 20 18 53 35 18 9 1 1 308
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (308)

Title and authors Publication Year
Dyspareunia, signs of epithelial disruption, sexual abstinence, and HIV status in female sex workers in Nairobi: a cross-sectional study.
Fischer B, Jaoko W, Kirui E, Muture B, Madegwa I, Kageni L
BMC Infectious Diseases 2023
HIV-1 protective epitope-specific CD8+ T cells in HIV-1-exposed seronegative individuals
Chikata T, Gatanaga H, Nguyen HT, Mizushima D, Zhang Y, Kuse N, Oka S, Takiguchi M
iScience 2023
High level of plasma TILRR protein is associated with faster HIV seroconversion
M Kashem, J Lischynski, B Stojak, L Li, X Yuan, B Liang, J Kimani, F Plummer, M Luo
EBioMedicine 2022
Natural Immunity against HIV-1: Progression of Understanding after Association Studies
Luo M
Viruses 2022
Immunological control of HIV-1 disease progression by rare protective HLA allele
Yu Zhang, Takayuki Chikata, Nozomi Kuse, Hayato Murakoshi, Hiroyuki Gatanaga, Shinichi Oka, Masafumi Takiguchi
Journal of virology 2022
CD8+ T-Cell Mediated Control of HIV-1 in a Unique Cohort With Low Viral Loads
AD Jones, S Khakhina, T Jaison, E Santos, S Smith, ZA Klase
Frontiers in microbiology 2021
The Potential Role of FREM1 and Its Isoform TILRR in HIV-1 Acquisition through Mediating Inflammation
MA Kashem, H Li, LR Liu, B Liang, RW Omange, FA Plummer, M Luo
International journal of molecular sciences 2021
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.
Cromarty R, Archary D
AIDS Research and Treatment 2020
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
N Saubi, A Kilpeläinen, Y Eto, CW Chen, À Olvera, T Hanke, C Brander, J Joseph-Munné
Human vaccines 2020
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
M Surenaud, M Montes, CS Arlehamn, A Sette, J Banchereau, K Palucka, JD Lelièvre, C Lacabaratz, Y Lévy, G Silvestri
PLoS pathogens 2019
Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
A Kilpeläinen, N Saubi, N Guitart, N Moyo, EG Wee, K Ravi, T Hanke, J Joseph
Frontiers in immunology 2019
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
E Broset, N Saubi, N Guitart, N Aguilo, S Uranga, A Kilpeläinen, Y Eto, T Hanke, J Gonzalo-Asensio, C Martín, J Joseph-Munné
Molecular Therapy — Methods & Clinical Development 2019
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
A Kilpeläinen, N Saubi, N Guitart, A Olvera, T Hanke, C Brander, J Joseph
Human vaccines 2019
Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned
A Kilpeläinen, M Maya-Hoyos, N Saubí, CY Soto, JJ Munne
Expert Review of Vaccines 2018
Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico
M Soto-Nava, S Avila-Ríos, H Valenzuela-Ponce, C García-Morales, JM Carlson, D Tapia-Trejo, D Garrido-Rodriguez, SN Alva-Hernández, TA García-Tellez, A Murakami-Ogasawara, SA Mallal, M John, MA Brockman, CJ Brumme, ZL Brumme, G Reyes-Teran, G Silvestri
Journal of virology 2017
Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity
A Mahant, N Saubi, Y Eto, N Guitart, JM Gatell, T Hanke, J Joseph
Human Vaccines & Immunotherapeutics 2017
Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity
A Mahant, N Saubi, Y Eto, N Guitart, JM Gatell, T Hanke, J Joseph
Human Vaccines & Immunotherapeutics 2017
Exploiting Mucosal Immunity for Antiviral Vaccines
A Iwasaki
Annual Review of Immunology 2016
Effects of the Cytotoxic T-Cells on the Dynamics of Co-Infection of HIV-1 and Mycobacterium tuberculosis
C Mufudza, SD Hove-Musekwa, ET Chiyaka
Journal of Tuberculosis Research 2016
Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes
H Murakoshi, T Akahoshi, M Koyanagi, T Chikata, T Naruto, R Maruyama, Y Tamura, N Ishizuka, H Gatanaga, S Oka, M Takiguchi
Journal of virology 2015
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial
PJ Kuebler, ML Mehrotra, JJ McConnell, SJ Holditch, BI Shaw, LF Tarosso, KS Leadabrand, JM Milush, VA York, RA Raposo, RG Cheng, EM Eriksson, V McMahan, DV Glidden, S Shiboski, RM Grant, DF Nixon, EG Kallás
Proceedings of the National Academy of Sciences 2015
HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes
SA Abdulhaqq, C Zorrilla, G Kang, X Yin, V Tamayo, KE Seaton, J Joseph, S Garced, GD Tomaras, KA Linn, AS Foulkes, L Azzoni, M VerMilyea, C Coutifaris, AV Kossenkov, L Showe, EN Kraiselburd, Q Li, LJ Montaner
Mucosal Immunology 2015
Identification of HLA-C restricted, HIV-1-specific CTL epitopes by peptide induced upregulation of HLA-C expression
A Stoll, S Bergmann, C Mummert, SM Mueller-Schmucker, BM Spriewald, EG Harrer, T Harrer
Journal of Immunological Methods 2015
Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya: Maternal HIV levels and IFN-γ responses
AY Liu, B Lohman-Payne, MH Chung, J Kiarie, J Kinuthia, J Slyker, B Richardson, D Lehman, C Farquhar, G John-Stewart
Clinical & Experimental Immunology 2015
Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage
D Archary, LJ Liebenberg, L Werner, S Tulsi, N Majola, N Naicker, S Dlamini, TJ Hope, N Samsunder, SS Karim, L Morris, JA Passmore, NJ Garrett, G Tachedjian
PloS one 2015
A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV
E Poteet, P Lewis, F Li, S Zhang, J Gu, C Chen, SO Ho, T Do, SM Chiang, G Fujii, Q Yao, S Lu
PloS one 2015
Serial Cervicovaginal Exposures With Replication-Deficient SIVsm Induce Higher Dendritic Cell (pDC) and CD4+ T-Cell Infiltrates Not Associated With Prevention but a More Severe SIVmac251 Infection of Rhesus Macaques:
SA Abdulhaqq, MI Martinez, G Kang, AS Foulkes, IV Rodriguez, SM Nichols, M Hunter, CA Sariol, LA Ruiz, BN Ross, X Yin, DW Speicher, AT Haase, PA Marx, Q Li, EN Kraiselburd, LJ Montaner
Journal of acquired immune deficiency syndromes (1999) 2014
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
KE Seaton, L Ballweber, A Lan, M Donathan, S Hughes, L Vojtech, MA Moody, HX Liao, BF Haynes, CG Galloway, BA Richardson, SA Karim, CS Dezzutti, MJ McElrath, GD Tomaras, F Hladik
PloS one 2014
Engineering new mycobacterial vaccine design for HIV–TB pediatric vaccine vectored by lysine auxotroph of BCG
N Saubi, E Gea-Mallorquí, P Ferrer, C Hurtado, S Sánchez-Úbeda, Y Eto, JM Gatell, T Hanke, J Joseph
Molecular Therapy — Methods & Clinical Development 2014
Influence of HLA class I haplotypes on HIV-1 seroconversion and disease progression in Pumwani sex worker cohort
R Sampathkumar, HO Peters, L Mendoza, T Bielawny, E Ngugi, J Kimani, C Wachihi, FA Plummer, M Luo
PloS one 2014
Association between Cellular Immune Activation, Target Cell Frequency, and Risk of Human Immunodeficiency Virus Type 1 Superinfection
CA Blish, OC Dogan, W Jaoko, RS McClelland, K Mandaliya, K Odem-Davis, BA Richardson, J Overbaugh
Journal of virology 2014
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
IS Fourati, AJ Grenier, É Jolette, N Merindol, P Ovetchkine, H Soudeyns
Journal of visualized experiments : JoVE 2014
HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities
KE Seaton, L Ballweber, A Lan, M Donathan, S Hughes, L Vojtech, MA Moody, HX Liao, BF Haynes, CG Galloway, BA Richardson, SA Karim, CS Dezzutti, MJ McElrath, GD Tomaras, F Hladik, K Broliden
PloS one 2014
Influence of HLA Class I Haplotypes on HIV-1 Seroconversion and Disease Progression in Pumwani Sex Worker Cohort
R Sampathkumar, HO Peters, L Mendoza, T Bielawny, E Ngugi, J Kimani, C Wachihi, FA Plummer, M Luo, JD Barbour
PloS one 2014
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8+ T cell specificity
X Pan, LC Huang, T Dong, Y Peng, V Cerundolo, S McGowan, G Ogg
Journal of Immunological Methods 2013
Ongoing Risk Behavior and the Presence of HCV-RNA Affect the Hepatitis C Virus (HCV)-Specific CD4 + T Cell Response
CH van Berg, NM Nanlohy, TJ van de Laar, M Prins, D Baarle
Viral Immunology 2013
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8(+) T cell specificity
X Pan, LC Huang, T Dong, Y Peng, V Cerundolo, S McGowan, G Ogg
Journal of Immunological Methods 2013
Vaccines
RW Sutter, OM Kew, SL Cochi, RB Aylward
Human vaccines 2013
Immune Quiescence: a model of protection against HIV infection
CM Card, TB Ball, KR Fowke
Retrovirology 2013
Two distinct functional patterns of hepatitis C Virus (HCV)-specific T cell responses in seronegative, aviremic patients
YS Choi, JE Lee, SJ Nam, JT Park, HS Kim, KH Choi, BS Kim, EC Shin
PloS one 2013
Two Distinct Functional Patterns of Hepatitis C Virus (HCV)-Specific T Cell Responses in Seronegative, Aviremic Patients
YS Choi, JE Lee, SJ Nam, JT Park, HS Kim, KH Choi, BS Kim, EC Shin, SA Rizza
PloS one 2013
Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides
K Watanabe, H Murakoshi, Y Tamura, M Koyanagi, T Chikata, H Gatanaga, S Oka, M Takiguchi
Microbes and infection / Institut Pasteur 2013
Benefit Sharing
D Schroeder, JC Lucas
2013
Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes
L Niu, H Cheng, S Zhang, S Tan, Y Zhang, J Qi, J Liu, GF Gao
Molecular Immunology 2013
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
JD Lifson, NL Haigwood
Cold Spring Harbor Perspectives in Medicine 2012
Natural Immunity to HIV: a delicate balance between strength and control
J Poudrier, V Thibodeau, M Roger
Clinical & developmental immunology 2012
A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort
M Luo, J Sainsbury, J Tuff, PA Lacap, XY Yuan, T Hirbod, J Kimani, C Wachihi, S Ramdahin, T Bielawny, J Embree, K Broliden, TB Ball, FA Plummer
Journal of virology 2012
HIV-1-Specific Enzyme-Linked Immunosorbent Spot Assay Responses in HIV-1-Exposed Uninfected Partners in Discordant Relationships Compared to Those in Low-Risk Controls
BL Guthrie, B Lohman-Payne, AY Liu, R Bosire, SV Nuvor, RY Choi, RD Mackelprang, JN Kiarie, SC Rosa, BA Richardson, GC John-Stewart, C Farquhar
Clinical and vaccine immunology : CVI 2012
HIV-1 Vaccine Trials: Evolving Concepts and Designs
MP Sanou, AS Groot, M Murphey-Corb, JA Levy, JK Yamamoto
The open AIDS journal 2012
Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
N Saubi, A Mbewe-Mvula, E Gea-Mallorqui, M Rosario, JM Gatell, T Hanke, J Joseph
PloS one 2012
The Immune System and Resisting HIV Infection
KR Fowke, CM Card, R Kaul
Models of Protection Against HIV/SIV 2012
HIV-1 superinfection :
L Waters, E Smit
Current Opinion in Infectious Diseases 2012
Immunization with Multiple Vaccine Modalities Induce Strong HIV-Specific Cellular and Humoral Immune Responses
D Hallengärd, SE Applequist, S Nyström, AK Maltais, M Marovich, B Moss, P Earl, K Nihlmark, B Wahren, A Bråve
Viral Immunology 2012
HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality
V Madhavi, SJ Kent, I Stratov
Expert Review of Clinical Immunology 2012
Sande's HIV/AIDS Medicine
JS Greenspan, D Greenspan
Sande's HIV/AIDS Medicine 2012
Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates
B Cameron, S Galbraith, H Li, A Lloyd
Journal of Viral Hepatitis 2012
Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals ▿ †
AJ Ritchie, SL Campion, J Kopycinski, Z Moodie, ZM Wang, K Pandya, S Moore, MK Liu, S Brackenridge, K Kuldanek, K Legg, MS Cohen, EL Delwart, BF Haynes, S Fidler, AJ McMichael, N Goonetilleke
Journal of virology 2011
Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review
MP Girard, S Osmanov, OM Assossou, MP Kieny
Vaccine 2011
Encyclopedia of Life Sciences
B Dahlbäck
Encyclopedia of Life Sciences 2011
Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population
W Song, D He, I Brill, R Malhotra, J Mulenga, S Allen, E Hunter, J Tang, RA Kaslow
PloS one 2011
AIDS vaccines and preexposure prophylaxis: is synergy possible?
JL Excler, W Rida, F Priddy, J Gilmour, AB McDermott, A Kamali, O Anzala, G Mutua, EJ Sanders, W Koff, S Berkley, P Fast
AIDS Research and Human Retroviruses 2011
Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women:
E Delwart, F Bernardin, TH Lee, V Winkelman, C Liu, H Sheppard, A Liu, R Greenblatt, K Anastos, J DeHovitz, M Nowicki, M Cohen, ET Golub, J Barbour, S Buchbinder, MP Busch
AIDS 2011
An immunological comparison between lipidated and non-lipidated multivalent HIV-1 peptides representing Gp120 and Gag hypervariable regions
H Ghunaim, A Kumar, J Torres, F Diaz-Mitoma, A Azizi
Vaccine 2011
Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population
W Song, D He, I Brill, R Malhotra, J Mulenga, S Allen, E Hunter, J Tang, RA Kaslow, JK Sandberg
PloS one 2011
CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers
EM Songok, B Osero, L McKinnon, MK Rono, W Apidi, EJ Matey, AF Meyers, M Luo, J Kimani, C Wachihi, BT Ball, FA Plummer, S Mpoke
Virology Journal 2010
Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness
AC van der Kuyl, K Kozaczynska, KK Ariën, Y Gali, VR Balázs, SJ Dekker, F Zorgdrager, G Vanham, B Berkhout, M Cornelissen
Retrovirology 2010
Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1
H Ji, TB Ball, Z Ao, J Kimani, X Yao, FA Plummer
Scandinavian Journal of Infectious Diseases 2010
HIV viral set point and host immune control in individuals with HIV-specific CD8+ T-cell responses prior to HIV acquisition:
R Kaul, KS MacDonald, NJ Nagelkerke, J Kimani, K Fowke, TB Ball, M Luo, A Kariri, W Jaoko, S Moses, S Rowland-Jones, FA Plummer
AIDS 2010
Resilience and mental health
DM Davydov, R Stewart, K Ritchie, I Chaudieu
Clinical Psychology Review 2010
Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients of Mumbai, India: Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients
U Shankarkumar, A Pawar, K Ghosh, S Bajpai, A Pazare
International Journal of Immunogenetics 2010
Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses
D Sirskyj, F Diaz-Mitoma, A Golshani, A Kumar, A Azizi
Immunology and Cell Biology 2010
The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
RA Koup, BS Graham, DC Douek
Nature Reviews Immunology 2010
Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners
Y Liu, A Woodward, H Zhu, T Andrus, J McNevin, J Lee, JI Mullins, L Corey, MJ McElrath, T Zhu
Journal of virology 2009
Persistent Immune Responses Induced by a Human Immunodeficiency Virus DNA Vaccine Delivered in Association with Electroporation in the Skin of Nonhuman Primates
F Martinon, K Kaldma, R Sikut, S Čulina, G Romain, M Tuomela, M Adojaan, A Männik, U Toots, T Kivisild, J Morin, P Brochard, B Delache, A Tripiciano, F Ensoli, I Stanescu, RL Grand, M Ustav
Human Gene Therapy 2009
The search for protection against HIV infection
R Detels
Annals of Epidemiology 2009
Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization
MD Co, ED Kilpatrick, AL Rothman
Immunology 2009
Repeated Rectal SHIVSF162P3Exposures Do Not Consistently Induce Sustained T Cell Responses Prior to Systemic Infection in the Repeat-Low Dose Preclinical Macaque Model
EN Kersh, W Luo, DR Adams, P Srinivasan, JM Smith, N Promadej-Lanier, D Ellenberger, JG Garcia-Lerma, S Butera, R Otten
AIDS Research and Human Retroviruses 2009
Case 11-2009 : A 47-Year-Old Man with Fever, Headache, Rash, and Vomiting
RC Cabot, NL Harris, JA Shepard, ES Rosenberg, AM Cort, SH Ebeling, CC Peters, SK Bell, ES Rosenberg
New England Journal of Medicine 2009
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV—Study in domestic pigs
T Mölder, M Adojaan, K Kaldma, M Ustav, R Sikut
Vaccine 2009
HIV Protocols
VR Prasad, GV Kalpana
HIV Protocols 2009
HIV Protocols
VR Prasad, GV Kalpana
HIV Protocols 2009
HIV Protocols
VR Prasad, GV Kalpana
HIV Protocols 2009
HIV Protocols
VR Prasad, GV Kalpana
HIV Protocols 2009
Broadly cross-reactive CD4+ and CD8+ T-cell responses to avian influenza A (H5N1) in healthy individuals in the UK and Viet Nam
Laurel Yong-Hwa Lee1, Lien Anh Ha2, Cameron Simmons2, Menno D. de Jong2, Nguyen Van Vinh Chau2, Reto Schumacher1, Yan Chun Peng1, Andrew J. McMichael1*, Jeremy J. Farrar2, Geoffrey L. Smith3, Alain R. M. Townsend4, Brigitte A. Askonas1, Sarah Rowland-Jones1, and Tao Dong1*
Journal of Clinical Investigation 2008
The Spread, Treatment, and Prevention of HIV-1: Evolution of a Global Pandemic
Myron S. Cohen, Nick Hellmann, Jay Levy, Kevin DeCock, and Joep Lange
Journal of Clinical Investigation 2008
Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries
SE Blondelle, R Moya-Castro, K Osawa, K Schroder, DB Wilson
Biopolymers 2008
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV
E Mizukoshi, C Eisenbach, BR Edlin, KP Newton, S Raghuraman, C Weiler-Normann, LH Tobler, MP Busch, M Carrington, JA McKeating, TR O'Brien, B Rehermann
The Journal of Infectious Diseases 2008
Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals
EC Speelmon, D Livingston-Rosanoff, AL Desbien, J Lee, WD Wick, F Hladik, MJ McElrath
AIDS Research and Human Retroviruses 2008
Not just sheer luck! Immune correlates of protection against HIV-1 infection
L Piacentini, C Fenizia, V Naddeo, M Clerici
Vaccine 2008
Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus
F Martinon, P Brochard, M Ripaux, B Delache, G Aurégan, B Vaslin, RL Grand
Vaccine 2008
Modeling HIV Immune Response and Validation with Clinical Data
HT Banks, M Davidian, S Hu, GM Kepler, ES Rosenberg
Journal of Biological Dynamics 2008
An Asymmetric Model of Heterozygote Advantage at Major Histocompatibility Complex Genes: Degenerate Pathogen Recognition and Intersection Advantage
RJ Stoffels, HG Spencer
Genetics 2008
Deficiency of HIV-Gag-Specific T Cells in Early Childhood Correlates with Poor Viral Containment
SH Huang, J Dunkley-Thompson, YH Tang, EA Macklin, J Steel-Duncan, I Singh-Minott, EG Ryland, M Smikle, BD Walker, CD Christie, ME Feeney
Journal of immunology (Baltimore, Md. : 1950) 2008
Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity
A Joseph, JH Zheng, A Follenzi, T DiLorenzo, K Sango, J Hyman, K Chen, A Piechocka-Trocha, C Brander, E Hooijberg, DA Vignali, BD Walker, H Goldstein
Journal of virology 2008
Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques
A Azizi, DE Anderson, JV Torres, A Ogrel, M Ghorbani, C Soare, P Sandstrom, J Fournier, F Diaz-Mitoma
Journal of immunology (Baltimore, Md. : 1950) 2008
Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.
van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Abdool Karim Q, Grobler A, Barnabas N, Iriogbe I, Abdool Karim SS
PloS one 2008
Human immunodeficiency virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India
S Pallikkuth, A Wanchu, A Bhatnagar, RK Sachdeva, M Sharma
Clinical and vaccine immunology : CVI 2007
The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy
XX Gu, FY Yue, CM Kovacs, MA Ostrowski
PloS one 2007
The potential of topical DNA vaccines adjuvanted by cytokines
J Lisziewicz, SA Calarota, F Lori
Expert Opinion on Biological Therapy 2007
Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women
T Hirbod, K Broliden
Journal of Internal Medicine 2007
Viral peptide immunogens: current challenges and opportunities
A Azizi, F Diaz-Mitoma
Journal of Peptide Science 2007
Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3
M Saini, E Hadas, DJ Volsky, MJ Potash
Vaccine 2007
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses
X Huang, L Liu, L Ren, C Qiu, Y Wan, J Xu
Vaccine 2007
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
S Létourneau, EJ Im, T Mashishi, C Brereton, A Bridgeman, H Yang, L Dorrell, T Dong, B Korber, AJ McMichael, T Hanke
PloS one 2007
HIV/AIDS Vaccine
JY Choi
Journal of Korean Medical Association 2007
Researching protective and promotive factors in mental health
V Patel, A Goodman
International Journal of Epidemiology 2007
HIV-1 Subtype C Gag-Specific T-Cell Responses in Relation to Human Leukocyte Antigens in a Diverse Population of HIV-Infected Ethiopians:
A Tsegaye, L Ran, D Wolday, B Petros, W Dorigo, E Piriou, T Messele, E Sanders, T Tilahun, D Eshetu, H Schuitemaker, RA Coutinho, F Miedema, J Borghans, D Baarle
Journal of acquired immune deficiency syndromes (1999) 2007
Mapping the future of HIV vaccines
GJ Nabel
Nature Reviews Microbiology 2007
The Role of Cytokines which Signal through the Common γ Chain Cytokine Receptor in the Reversal of HIV Specific CD4+ and CD8+ T Cell Anergy
XX Gu, FY Yue, CM Kovacs, MA Ostrowski, D Nixon
PloS one 2007
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
S Létourneau, EJ Im, T Mashishi, C Brereton, A Bridgeman, H Yang, L Dorrell, T Dong, B Korber, AJ McMichael, T Hanke, D Nixon
PloS one 2007
Availability of a Diversely Avid CD8 + T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p24 19–27 Epitope
KL Schaubert, DA Price, N Frahm, J Li, HL Ng, A Joseph, E Paul, B Majumder, V Ayyavoo, E Gostick, S Adams, FM Marincola, AK Sewell, M Altfeld, JM Brenchley, DC Douek, OO Yang, C Brander, H Goldstein, J Kan-Mitchell
Journal of immunology (Baltimore, Md. : 1950) 2007
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett
Current HIV/AIDS Reports 2006
Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans
E Bégaud, L Chartier, V Marechal, J Ipero, J Léal, P Versmisse, G Breton, A Fontanet, C Capoulade-Metay, H Fleury, F Barré-Sinoussi, D Scott-Algara, G Pancino
Retrovirology 2006
Resistance to HIV infection
M Marmor, K Hertzmark, SM Thomas, PN Halkitis, M Vogler
Journal of urban health : bulletin of the New York Academy of Medicine 2006
Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma
M Lambert, M Gannagé, A Karras, M Abel, C Legendre, D Kerob, F Agbalika, PM Girard, C Lebbe, S Caillat-Zucman
Blood 2006
Protective immunity against hepatitis C virus infection
LN Elliott, AR Lloyd, JB Ziegler, RA Ffrench
Immunology and Cell Biology 2006
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett
Current Infectious Disease Reports 2006
HIV VACCINES
AJ McMichael
Annual Review of Immunology 2006
Amplified transmission of HIV-1: missing link in the HIV pandemic
MS Cohen
Transactions of the American Clinical and Climatological Association 2006
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection
J Yu, H Chen, H Horton, A Bansal, JM McElrath, R Reichman, P Goepfert, X Jin
Journal of Medical Virology 2006
Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior
T Hirbod, J Nilsson, S Andersson, C Uberti-Foppa, D Ferrari, M Manghi, J Andersson, L Lopalco, K Broliden
JAIDS Journal of Acquired Immune Deficiency Syndromes 2006
Suppressor of cytokine signaling 1 inhibition strategy to enhance anti-HIV vaccination
XT Song, M Aldrich, SY Chen
Expert Review of Vaccines 2006
Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities
K Luzuriaga, ML Newell, F Dabis, JL Excler, JL Sullivan
The Lancet 2006
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Z Moodie, Y Huang, L Gu, J Hural, SG Self
Journal of Immunological Methods 2006
Interactive association of proviral load and IFN-γ-secreting T cell responses in HIV-1C infection
VA Novitsky, PB Gilbert, K Shea, MF McLane, N Rybak, I Klein, I Thior, T Ndung'u, TH Lee, ME Essex
Virology 2006
Progress towards an HIV vaccine based on recombinant Bacillus Calmette–Guérin: failures and challenges
J Joseph, N Saubi, E Pezzat, JM Gatell
Expert Review of Vaccines 2006
Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes:
J Xu, L Ren, X Huang, C Qiu, Y Liu, Y Liu, Y Shao
AIDS 2006
Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response
JD Boyer, S Kumar, T Robinson, R Parkinson, L Wu, M Lewis, DI Watkins, DB Weiner
Journal of Medical Primatology 2006
Cross-Clade Conservation of HIV Type 1 Nef Immunodominant Regions Recognized by CD8+T Cells of HIV Type 1 CRF02_AG-Infected Ivorian (West Africa)
A Inwoley, P Recordon-Pinson, M Dupuis, J Gaston, M Genête, A Minga, F Letourneur, F Rouet, J Choppin, H Fleury, JG Guillet, M Andrieu
AIDS Research and Human Retroviruses 2005
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
SH Kaufmann, AJ McMichael
Nature Medicine 2005
Major Histocompatibility Complex Class II (HLA-DRB and -DQB) Allele Frequencies in Botswana: Association with Human Immunodeficiency Virus Type 1 Infection
T Ndung'u, S Gaseitsiwe, E Sepako, F Doualla-Bell, T Peter, S Kim, I Thior, VA Novitsky, M Essex
Clinical and vaccine immunology : CVI 2005
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants☆
JA Slyker, BL Lohman, DA Mbori-Ngacha, M Reilly, EG Wee, T Dong, AJ McMichael, SL Rowland-Jones, T Hanke, G John-Stewart
Vaccine 2005
Global human genetics of HIV-1 infection and China
TF ZHU, TJ FENG, X XIAO, H WANG, BP ZHOU
Cell Research 2005
Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera
SA Tenenbaum, CA Morris, SS Alexander, HE McFerrin, RF Garry, CA Leissinger
Virology Journal 2005
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes
F Bernardin, D Kong, L Peddada, LA Baxter-Lowe, E Delwart
Journal of virology 2005
Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post-Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials
BE Shepherd, PB Gilbert, Y Jemiai, A Rotnitzky
Biometrics 2005
The challenges of HIV vaccine development and testing
WA Burgers, C Williamson
Best Practice & Research Clinical Obstetrics & Gynaecology 2005
Mucosal Immunology
WR Brown
Mucosal Immunology 2005
Clustered epitopes within the Gag–Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens
E Bolesta, J Gzyl, A Wierzbicki, D Kmieciak, A Kowalczyk, Y Kaneko, A Srinivasan, D Kozbor
Virology 2005
Might male circumcision be more protective against HIV in the highly exposed? An immunological hypothesis:
MJ Wawer, SJ Reynolds, D Serwadda, G Kigozi, N Kiwanuka, RH Gray
AIDS 2005
Contrasting B cell- and T cell-based protective vaccines
VA Jansen, HK Altes, GA Funk, D Wodarz
Journal of Theoretical Biology 2005
Les mécanismes de résistance à la transmission sexuelle du VIH-1
A Eberhard, B Ponceau, F Biron, B Verrier
Médecine et Maladies Infectieuses 2005
Is there a role for plant-made vaccines in the prevention of HIV/AIDS?
DE Webster, MC Thomas, R Pickering, A Whyte, IB Dry, PR Gorry, SL Wesselingh
Immunology and Cell Biology 2005
The CD160+ CD8high cytotoxic T cell subset correlates with response to HAART in HIV-1+ patients
MH Nikolova, MN Muhtarova, HB Taskov, K Kostov, L Vezenkov, A Mihova, L Boumsell, A Bensussan
Cellular Immunology 2005
MHC, health, color, and reproductive success in sand lizards
M Olsson, T Madsen, E Wapstra, B Silverin, B Ujvari, H Wittzell
Behavioral Ecology and Sociobiology 2005
Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences
TJ Scriba, J Megede, RH Glashoff, FK Treurnicht, SW Barnett, EJ van Rensburg
Vaccine 2005
Current Issues in the Development of a Vaccine to Prevent Human Immunodeficiency Virus: Insights from the Society of Infectious Diseases Pharmacists
EG Sahloff
Pharmacotherapy 2005
Significance of the detection of HIV-1 gag- and/or pol-CD8/A2 T-lymphocytes in HIV-patients
R Wu, GC Owen, T Liu, GQ Shen, RI Morris
Immunology Letters 2005
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques
J Su, MA Luscher, Y Xiong, T Rustam, RR Amara, E Rakasz, HL Robinson, KS MacDonald
International Immunology 2005
A la recherche du vaccin contre le SIDA
MP Girard
Bulletin de l'Académie nationale de médecine 2005
Combined Effect of CCR5-Δ32 Heterozygosity and the CCR5 Promoter Polymorphism −2459 A/G on CCR5 Expression and Resistance to Human Immunodeficiency Virus Type 1 Transmission
F Hladik, H Liu, E Speelmon, D Livingston-Rosanoff, S Wilson, P Sakchalathorn, Y Hwangbo, B Greene, T Zhu, MJ McElrath
Journal of virology 2005
CD8 + T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligodeoxynucleotides
JQ Jiang, A Patrick, RB Moss, KL Rosenthal
Journal of virology 2005
Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity
A Sette, J Sidney, HH Bui, MF del Guercio, J Alexander, J Loffredo, DI Watkins, BR Mothé
Immunogenetics 2005
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy
G Borkow, Z Bentwich
Clinical microbiology reviews 2004
Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa
AM Masemola, TN Mashishi, G Khoury, H Bredell, M Paximadis, T Mathebula, D Barkhan, A Puren, E Vardas, M Colvin, L Zijenah, D Katzenstein, R Musonda, S Allen, N Kumwenda, T Taha, G Gray, J McIntyre, SA Karim, HW Sheppard, CM Gray
Journal of immunology (Baltimore, Md. : 1950) 2004
Insights Into the Role of Host Genetic and T-Cell Factors in Resistance to HIV Transmission From Studies of Highly HIV-Exposed Thais
JM McNicholl, N Promadej
Immunologic Research 2004
Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals
Q Lizeng, C Nilsson, S Sourial, S Andersson, O Larsen, P Aaby, M Ehnlund, E Björling
Journal of virology 2004
DNA vaccines against human immunodeficiency virus type 1
MJ Estcourt, AJ McMichael, T Hanke
Immunological Reviews 2004
Impact of host genetics on HIV disease progression and treatment
D Nolan, S Gaudieri, M John, S Mallal
AIDS 2004
Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens
Y Paterson, R Johnson
Expert Review of Vaccines 2004
HIV Type 1 Antigen-Responsive CD4+T-Lymphocytes in Exposed Yet HIV Type 1 Seronegative Ugandans
A Kebba, P Kaleebu, J Serwanga, S Rowland, D Yirrell, R Downing, J Gilmour, N Imami, F Gotch, J Whitworth
AIDS Research and Human Retroviruses 2004
Human Leukocyte Antigen (HLA) B*18 and Protection against Mother-to-Child HIV Type 1 Transmission
C Farquhar, S Rowland-Jones, D Mbori-Ngacha, M Redman, B Lohman, J Slyker, P Otieno, E Obimbo, T Rostron, J Ochieng, J Oyugi, R Bosire, G John-Stewart
AIDS Research and Human Retroviruses 2004
Cross-Clade CD8 T-Cell Responses to HIVIIIB and Chinese B??? and C/B??? Viruses in North American and Chinese HIV-Seropositive Donors:
V Fran??ois-Bongarcon, Y Feng, SK Lee, G Chen, P Shankar, Y Liu, X Tao, Y Shao, J Lieberman
JAIDS Journal of Acquired Immune Deficiency Syndromes 2004
Approaches for the design and evaluation of HIV-1 DNA vaccines
SA Calarota, DB Weiner
Expert Review of Vaccines 2004
Therapeutic vaccination against HIV
B Wahren, M Liu
Expert Review of Vaccines 2004
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
G Pantaleo, RA Koup
Nature Medicine 2004
HIV Type 1-Specific Inter- and Intrasubtype Cellular Immune Responses in HIV Type 1-Infected Ugandans
A Rutebemberwa, B Auma, J Gilmour, G Jones, D Yirrell, S Rowland, N Imami, C Watera, P Kaleebu, J Whitworth, F Gotch
AIDS Research and Human Retroviruses 2004
Th1/Th2 cells in inflammatory disease states: therapeutic implications
RB Moss, T Moll, M El-Kalay, C Kohne, WS Hoo, J Encinas, DJ Carlo
Expert Opinion on Biological Therapy 2004
Full-Length gag Sequences of HIV Type 1 Subtype C Recent Seroconverters from Pune, India
S Kurle, S Tripathy, S Jadhav, K Agnihotri, R Paranjape
AIDS Research and Human Retroviruses 2004
HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis
Rupert Kaul, John Rutherford, Sarah L Rowland-Jones, Joshua Kimani, James Isaiah Onyango, Keith Fowke, Kelly MacDonald, Job J Bwayo, Andrew J McMichael, Francis A Plummer
AIDS 2004
Risk Associated HIV-1 Cross-Clade Resistance of Whole Peripheral Blood Mononuclear Cells From Exposed Uninfected Individuals With Wild-Type CCR5:
R John, S Arango-Jaramillo, GJ Finny, DH Schwartz
Journal of acquired immune deficiency syndromes (1999) 2004
Structures of HLA-A*1101 Complexed with Immunodominant Nonamer and Decamer HIV-1 Epitopes Clearly Reveal the Presence of a Middle, Secondary Anchor Residue
L Li, M Bouvier
Journal of immunology (Baltimore, Md. : 1950) 2004
Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1
K Ritola, CD Pilcher, SA Fiscus, NG Hoffman, JA Nelson, KM Kitrinos, CB Hicks, JJ Eron, R Swanstrom
Journal of virology 2004
Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells
F Hladik, A Desbien, J Lang, L Wang, Y Ding, S Holte, A Wilson, Y Xu, M Moerbe, S Schmechel, MJ McElrath
Journal of immunology (Baltimore, Md. : 1950) 2003
HIV vaccines 1983–2003
AJ McMichael, T Hanke
Nature Medicine 2003
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines
WP Kong, Y Huang, ZY Yang, BK Chakrabarti, Z Moodie, GJ Nabel
Journal of virology 2003
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression
C Farquhar, G John-Stewart
Clinical & Experimental Immunology 2003
A review of vaccines for HIV prevention
M Mwau, AJ McMichael
The Journal of Gene Medicine 2003
Demystified. Human endogenous retroviruses
PN Nelson, PR Carnegie, J Martin, HD Ejtehadi, P Hooley, D Roden, S Rowland-Jones, P Warren, J Astley, PG Murray
Molecular pathology : MP 2003
Repetitive and consistent cervicovaginal exposure to certain viral pathogens appears to protect against their sexual acquisition in some women: potential mechanisms
J Laurence
Journal of Reproductive Immunology 2003
Vaccine for AIDS and Ebola virus infection
GJ Nabel
Virus Research 2003
Interleukin 12-Augmented T Cell Proliferation of Peripheral Blood Mononuclear Cells from HIV-Seropositive Individuals Is Associated with Interleukin 12 Receptor β2 Upregulation
ML Jones, JM Young, QR Huang, RL Puls, CA Webber, EM Benson
AIDS Research and Human Retroviruses 2003
Cross-Reactive CD8+ T Cell Epitopes Identified in US Adolescent Minorities
S Sabbaj, A Bansal, GD Ritter, C Perkins, BH Edwards, E Gough, J Tang, JJ Szinger, B Korber, CM Wilson, RA Kaslow, MJ Mulligan, PA Goepfert
JAIDS Journal of Acquired Immune Deficiency Syndromes 2003
AIDS and Other Manifestations of HIV Infection
D Ashkin, Y Hale, E Hollender, M Lauzardo, M Narita, AE Pitchenik, M Salfinger, JJ Stambaugh
AIDS and Other Manifestations of HIV Infection 2003
Design and construction of T-lymphocyte epitope-based therapeutic HIV-1 vaccines
MJ Newman, D McKinney, R Chesnut, A Sette, C Wilson, B Livingston
Clinical and Applied Immunology Reviews 2003
Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development
C Williamson, L Morris, MF Maughan, LH Ping, SA Dryga, R Thomas, EA Reap, T Cilliers, J Harmelen, A Pascual, G Ramjee, G Gray, R Johnston, SA Karim, R Swanstrom
AIDS Research and Human Retroviruses 2003
Suppression of HIV-1 Replication by HIV-1-Irrelevant CD8 + Cytotoxic T Lymphocytes Resulting in Preservation of Persistently HIV-1-Infected Cells In Vitro
H Liu, T Ohashi, T Masuda, X Zhou, M Kubo, M Kannagi
Viral Immunology 2003
The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients
D Vázquez-Blomquist, E Iglesias, EE González-Horta, CA Duarte
Vaccine 2003
Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects:
J Eyeson, D King, MJ Boaz, E Sefia, S Tomkins, A Waters, PJ Easterbrook, A Vyakarnam
AIDS 2003
Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines
J zur Megede, GR Otten, B Doe, H Liu, L Leung, JB Ulmer, JJ Donnelly, SW Barnett
Journal of virology 2003
Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome
JP McGettigan, K Naper, J Orenstein, M Koser, PM McKenna, MJ Schnell
Journal of virology 2003
Primary replication of a recombinant Sendai virus vector in macaques
K Terao, Y Suzaki, Y Ami, A Takeda, H Nakamura, A Kato, T Matano, M Kano, Y Nagai
Journal of General Virology 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure
JH Skurnick, P Palumbo, A DeVico, BL Shacklett, FT Valentine, M Merges, R Kamin-Lewis, J Mestecky, T Denny, GK Lewis, J Lloyd, R Praschunus, A Baker, DF Nixon, S Stranford, R Gallo, SH Vermund, DB Louria
The Journal of Infectious Diseases 2002
Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
G Borkow, Z Bentwich
Clinical and vaccine immunology : CVI 2002
Dendritic Cell Amplification of HIV Type 1-Specific CD8+T Cell Responses in Exposed, Seronegative Heterosexual Women
BL Shacklett, RE Means, M Larsson, DT Wilkens, TJ Beadle, MJ Merritt, N Bhardwaj, PE Palumbo, JH Skurnick, DB Louria, DF Nixon
AIDS Research and Human Retroviruses 2002
Design and tests of an HIV vaccine
A McMichael, M Mwau, T Hanke
British Medical Bulletin 2002
Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients
K Fukada, H Tomiyama, C Wasi, T Matsuda, S Kusagawa, H Sato, S Oka, Y Takebe, M Takiguchi
AIDS 2002
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
V Novitsky, UR Smith, P Gilbert, MF McLane, P Chigwedere, C Williamson, T Ndung'u, I Klein, SY Chang, T Peter, I Thior, BT Foley, S Gaolekwe, N Rybak, S Gaseitsiwe, F Vannberg, R Marlink, TH Lee, M Essex
Journal of virology 2002
The search for an HIV vaccine
MW Makgoba, N Solomon, TJ Tucker
BMJ (Clinical research ed.) 2002
HIV vaccine strategies
GJ Nabel
Vaccine 2002
HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity
G Makedonas, J Bruneau, H Lin, RP Sékaly, F Lamothe, NF Bernard
AIDS 2002
OPINION — VACCINES: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?
A McMichael, T Hanke
Nature Reviews Immunology 2002
Development of a novel allo-independent HIV-1 virus preparation for use in immunoassays
S Koesters, WJ Rutherford, KR Fowke
Journal of Immunological Methods 2002
HIV-1 Therapeutic Vaccines
SK Loes, B Autran
Journal of Infection 2002
Human Cytotoxic T Lymphocyte Responses to Live Attenuated 17D Yellow Fever Vaccine: Identification of HLA-B35-Restricted CTL Epitopes on Nonstructural Proteins NS1, NS2b, NS3, and the Structural Protein E
MD Co, M Terajima, J Cruz, FA Ennis, AL Rothman
Virology 2002
Molecular virology and immunology of HIV infection
J Chinen, WT Shearer
Journal of Allergy and Clinical Immunology 2002
What information is needed to design effective vaccination against intracellular pathogens causing chronic disease?
PA Bretscher, D Hamilton, O Ogunremi
Expert Review of Vaccines 2002
AIDS Vaccine Research
V Lukashov, J Goudsmit, W Paxton
AIDS Vaccine Research 2002
AIDS Vaccine Research: Challenges and Opportunities
G Nabel
AIDS Vaccine Research 2002
Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats
MJ Burkhard, L Valenski, S Leavell, GA Dean, WA Tompkins
Vaccine 2002
Effects of MHC Class I on HIV/SIV Disease in Primates:
M Carrington, RE Bontrop
AIDS, Supplement 2002
Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects:
C Devito, J Hinkula, R Kaul, J Kimani, P Kiama, L Lopalco, C Barass, S Piconi, D Trabattoni, JJ Bwayo, F Plummer, M Clerici, K Broliden
Journal of acquired immune deficiency syndromes (1999) 2002
CD8+ T-cell immunity to HIV infection
P Piazza, Z Fan, CR Rinaldo
Clinics in Laboratory Medicine 2002
HIV: Bad news for stop–start therapy?
AJ McMichael, SL Rowland-Jones
Nature 2002
Boosting of SIV-Specific T Cell Responses in Rhesus Macaques That Resist Repeated Intravaginal Challenge with SIVmac251
BL Shacklett, B Ling, RS Veazey, A Luckay, WJ Moretto, DT Wilkens, J Hu, ZR Israel, DF Nixon, PA Marx
AIDS Research and Human Retroviruses 2002
Current strategies in the treatment of HIV infection
OJ Cohen, AS Fauci
Disease-a-Month 2002
Induction of a Strong HIV-Specific CD8 + T Cell Response in Mice Using a Fowlpox Virus Vector Expressing an HIV-1 Multi-CTL-Epitope Polypeptide
DV Blomquist, P Green, SM Laidlaw, MA Skinner, P Borrow, CA Duarte
Viral Immunology 2002
Coreceptor Utilization of HIV Type 1 Subtype E Viral Isolates from Thai Men with HIV Type 1-Infected and Uninfected Wives
U Utaipat, A Duerr, DL Rudolph, C Yang, ST Butera, D Lupo, T Pisell, A Tangmunkongvorakul, N Kamtorn, N Nantachit, T Nagachinta, V Suriyanon, V Robison, KE Nelson, N Sittisombut, RB Lal
AIDS Research and Human Retroviruses 2002
HIV-1 vaccines: the search continues
JP McGettigan, PM McKenna, MJ Schnell
Clinics in Laboratory Medicine 2002
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance
H Loemba, B Brenner, MA Parniak, S Ma'ayan, B Spira, D Moisi, M Oliveira, M Detorio, M Essex, MA Wainberg
Antiviral Research 2002
Human Immunodeficiency Virus (HIV)–Specific Cellular Immune Responses in Newborns Exposed to HIV In Utero
L Kuhn, S Meddows‐Taylor, G Gray, C Tiemessen
Clinical Infectious Diseases 2002
HIV T cell vaccines, the importance of clades
A McMichael, M Mwau, T Hanke
Vaccine 2002
The ELISPOT Assay: An Easily Transferable Method for Measuring Cellular Responses and Identifying T Cell Epitopes
T Mashishi, CM Gray
Clinical chemistry and laboratory medicine : CCLM / FESCC 2002
Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy
MM Thomson, L Pérez-Álvarez, R Nájera
The Lancet Infectious Diseases 2002
Epidermal Powder Immunization with a Recombinant HIV gp120 Targets Langerhans Cells and Induces Enhanced Immune Responses
D Chen, C Zuleger, Q Chu, YF Maa, J Osorio, LG Payne
AIDS Research and Human Retroviruses 2002
Le long chemin du vaccin contre le sida
M Girard
Annales de l'Institut Pasteur/Actualités 2002
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades
Thomas G Bird, Rupert Kaul, Timothy Rostron, Joshua Kimani, Joanne Embree, Paul P Dunn, Job J Bwayo, Francis A Plummer, Sarah L Rowland-Jones, Tao Dong,
AIDS 2002
HIV-1 Polymorphism: a Challenge for Vaccine Development - A Review
MG Morgado, ML Guimarães, B Galvão-Castro
Memórias do Instituto Oswaldo Cruz 2002
Lymphocyte Activation and Immune Regulation IX
S Gupta, E Butcher, W Paul
Lymphocyte Activation and Immune Regulation IX 2002
Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C
V Novitsky, H Cao, N Rybak, P Gilbert, MF McLane, S Gaolekwe, T Peter, I Thior, T Ndung'u, R Marlink, TH Lee, M Essex
Journal of virology 2002
Rhesus Macaque Resistance to Mucosal Simian Immunodeficiency Virus Infection Is Associated with a Postentry Block in Viral Replication
B Peng, R Voltan, L Lim, Y Edghill-Smith, S Phogat, DS Dimitrov, K Arora, M Leno, S Than, R Woodward, PD Markham, M Cranage, M Robert-Guroff
Journal of virology 2002
Computer-Based Design of an HLA-Haplotype and HIV-Clade Independent Cytotoxic T-Lymphocyte (CTL) Assay for Monitoring HIV-Specific Immunity
M Amicosante, C Gioia, C Montesano, R Casetti, S Topino, G DOffizi, G Cappelli, G Ippolito, V Colizzi, F Poccia, LP Pucillo
Molecular Medicine 2002
AIDS in Africa
M Essex, S Mboup, PJ Kanki, RG Marlink, SD Tlou, M Holme
2002
Human Immunodeficiency Virus-Specific CD8 + T Cells in Human Breast Milk
S Sabbaj, BH Edwards, MK Ghosh, K Semrau, S Cheelo, DM Thea, L Kuhn, GD Ritter, MJ Mulligan, PA Goepfert, GM Aldrovandi
Journal of virology 2002
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal
Science 2002
Characterization of the Peptide-Binding Specificity of Mamu-B*17 and Identification of Mamu-B*17-Restricted Epitopes Derived from Simian Immunodeficiency Virus Proteins
BR Mothé, J Sidney, JL Dzuris, ME Liebl, S Fuenger, DI Watkins, A Sette
Journal of immunology (Baltimore, Md. : 1950) 2002
The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype
AC Boon, G de Mutsert, YM Graus, RA Fouchier, K Sintnicolaas, AD Osterhaus, GF Rimmelzwaan
Journal of virology 2002
Detailed Analysis of CD4 + Th Responses to Envelope and Gag Proteins of Simian Immunodeficiency Virus Reveals an Exclusion of Broadly Reactive Th Epitopes from the Glycosylated Regions of Envelope
S Sarkar, V Kalia, M Murphey-Corb, RC Montelaro
Journal of immunology (Baltimore, Md. : 1950) 2002
Sustained Peptide-Specific Gamma Interferon T-Cell Response in Rhesus Macaques Immunized with Human Immunodeficiency Virus gag DNA Vaccines
MJ Caulfield, S Wang, JG Smith, TW Tobery, X Liu, ME Davies, DR Casimiro, TM Fu, A Simon, RK Evans, EA Emini, J Shiver
Journal of virology 2002
Diversity Considerations in HIV-1 Vaccine Selection
B Gaschen, J Taylor, K Yusim, B Foley, F Gao, D Lang, V Novitsky, B Haynes, BH Hahn, T Bhattacharya, B Korber
Science 2002
Magnitude of Functional CD8 + T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma
BH Edwards, A Bansal, S Sabbaj, J Bakari, MJ Mulligan, PA Goepfert
Journal of virology 2002
Differences Between T Cell Epitopes Recognized After Immunization and After Infection
TU Vogel, H Horton, DH Fuller, DK Carter, K Vielhuber, DH OConnor, T Shipley, J Fuller, G Sutter, V Erfle, N Wilson, LJ Picker, DI Watkins
Journal of immunology (Baltimore, Md. : 1950) 2002
HIV vaccines: Biological and clinical considerations
MP DSouza, MA Allen, MI Johnston
Current Infectious Disease Reports 2002
Neutralizing Antibodies Mechanism of Neutralization and Protective Activity Against HIV-1
Y Xiao, X Dong, YH Chen
Immunologic Research 2002
Late seroconversion in HIV-1 "resistant" prostitutes despite pre-existing HIV-1 specific CD8+ responses: association with reduced HIV exposure
Rupert Kaul, Sarah L. Rowland-Jones, Joshua Kimani, Tao Dong, Hong-Bing Yang, Peter Kiama, Timothy Rostron, Ephantus Njagi, Job J. Bwayo, Kelly S. MacDonald, Andrew J. McMichael, Francis A. Plummer
Journal of Clinical Investigation 2001
HIV specific CD8+ lymphocyte responses correlate with resistance to HIV infection, and target different epitopes in seronegative and infected subjects
Rupert Kaul, Tao Dong, Francis A. Plummer, Joshua Kimani, Timothy Rostron, Peter Kiama, Ephantus Njagi, Erastus Irungu, Bashir Farah, Julius Oyugi, Rana Chakraborty, Kelly S. MacDonald, Job J. Bwayo, Andrew McMichael, Sarah L. Rowland-Jones
Journal of Clinical Investigation 2001
The realistic hope for curbing the expanding HIV pandemic
Norman Letvin, Bruce D. Walker
Journal of Clinical Investigation 2001
Cellular immune responses to HIV
AJ McMichael, SL Rowland-Jones
Nature 2001
The influence of HLA genotype on AIDS
M Carrington, SJ O'Brien
Annual Review of Medicine 2001
Current Protocols in Immunology
EH Leiter
Current Protocols in Immunology 2001
Perspectives on inducing efficient immune control of HIV-1 replication - a new goal for HIV therapeutics?
RP Bucy, JM Kilby
AIDS 2001
Directex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
AM Grabowska, F Lechner, P Klenerman, PJ Tighe, S Ryder, JK Ball, BJ Thomson, WL Irving, RA Robins
European Journal of Immunology 2001
Human Immunodeficieny Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection
DE Cohen, BD Walker
Clinical Infectious Diseases 2001
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
DK Wong, DD Dudley, PB Dohrenwend, GM Lauer, RT Chung, DL Thomas, BD Walker
Journal of virology 2001
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design
V Novitsky, N Rybak, MF McLane, P Gilbert, P Chigwedere, I Klein, S Gaolekwe, SY Chang, T Peter, I Thior, T Ndung'u, F Vannberg, BT Foley, R Marlink, TH Lee, M Essex
Journal of virology 2001
Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates
JP McGettigan, HD Foley, IM Belyakov, JA Berzofsky, RJ Pomerantz, MJ Schnell
Journal of virology 2001
Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted
Y Guan, JB Whitney, M Detorio, MA Wainberg
Journal of virology 2001
Failure to detect HLA-A*6802-restricted CD8+ T cells specific for Chlamydia trachomatis antigens in subjects from trachoma-endemic communities
OS Mahdi, HC Whittle, H Joof, DC Mabey, RL Bailey
Clinical & Experimental Immunology 2001
Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals
J Engelmayer, M Larsson, A Lee, M Lee, WI Cox, RM Steinman, N Bhardwaj
Journal of virology 2001
HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand
B Sriwanthana, T Hodge, TD Mastro, CS Dezzutti, K Bond, HA Stephens, LG Kostrikis, K Limpakarnjanarat, NL Young, SH Qari, RB Lal, D Chandanayingyong, JM McNicholl
AIDS Research and Human Retroviruses 2001
High Levels of CD8-Positive Lymphocytes Expressing CD45R0, Granzyme B, and Ki-67 in Lymph Nodes of HIV-Infected Individuals Are Not Associated with Increased Mortality
C Espersen, B Pakkenberg, E Harder, G Pallesen, J Gerstoft, BK Pedersen, H Ullum
AIDS Research and Human Retroviruses 2001
Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design
KS MacDonald, L Matukas, JE Embree, K Fowke, J Kimani, NJ Nagelkerke, J Oyugi, P Kiama, R Kaul, MA Luscher, S Rowland-Jones, J Ndinya-Achola, E Ngugi, JJ Bwayo, FA Plummer
Immunology Letters 2001
Characterization of High-Risk HIV-1 Seronegative Hemophiliacs
JR Salkowitz, SF Purvis, H Meyerson, P Zimmerman, TR O'Brien, L Aledort, ME Eyster, M Hilgartner, C Kessler, BA Konkle, GC White, JJ Goedert, MM Lederman
Clinical Immunology 2001
A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay
TW Tobery, S Wang, XM Wang, MP Neeper, KU Jansen, WL McClements, MJ Caulfield
Journal of Immunological Methods 2001
Recent developments in human HIV-1 vaccine
D Dabelstein, B Cromer
Family Practice 2001
DNA Vaccination of Macaques with Several Different Nef Sequences Induces Multispecific T Cell Responses
I Couillin, F Letourneur, P Lefèbvre, JG Guillet, F Martinon
Virology 2001
Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody
N Polyanskaya, LA Bergmeier, SA Sharpe, N Cook, S Leech, G Hall, M Dennis, P Haaft, J Heeney, F Manca, T Lehner, MP Cranage
Virology 2001
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
K Broliden, J Hinkula, C Devito, P Kiama, J Kimani, D Trabbatoni, JJ Bwayo, M Clerici, F Plummer, R Kaul
Immunology Letters 2001
HIV in the Female Genital Tract: Viral Shedding and Mucosal Immunity:
L Al-Harthi, A Landay
Clinical Obstetrics and Gynecology 2001
Challenges and opportunities for development of an AIDS vaccine
GJ Nabel
Nature 2001
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
S L Rowland-Jones, S Pinheiro, R Kaul, P Hansasuta, G Gillespie, T Dong, F A Plummer, J B Bwayo, S Fidler, J Weber, A McMichael, V Appay
Immunology Letters 2001
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers
R Kaul, S L Rowland-Jones, J Kimani, K Fowke, T Dong, P Kiama, J Rutherford, E Njagi, F Mwangi, T Rostron, J Onyango, J Oyugi, K S MacDonald, J J Bwayo, F A Plummer
Immunology Letters 2001
Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA Alleles
CL Day, AK Shea, MA Altfeld, DP Olson, SP Buchbinder, FM Hecht, ES Rosenberg, BD Walker, SA Kalams
Journal of virology 2001
Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells
J Lisziewicz, DI Gabrilovich, G Varga, J Xu, PD Greenberg, SK Arya, M Bosch, JP Behr, F Lori
Journal of virology 2001
Route of Simian Immunodeficiency Virus Inoculation Determines the Complexity but Not the Identity of Viral Variant Populations That Infect Rhesus Macaques
JL Greenier, CJ Miller, D Lu, PJ Dailey, FX Lu, KJ Kunstman, SM Wolinsky, ML Marthas
Journal of virology 2001
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber, B Gaschen, K Yusim, R Thakallapally, C Kesmir, V Detours
British Medical Bulletin 2001
HIV-1 transmission and acute HIV-1 infection
P Hansasuta, SL Rowland-Jones
British Medical Bulletin 2001
Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines
RA Kaslow, C Rivers, J Tang, TJ Bender, PA Goepfert, RE Habib, K Weinhold, MJ Mulligan
Journal of virology 2001
CD8 + Lymphocytes from Simian Immunodeficiency Virus-Infected Rhesus Macaques Recognize 14 Different Epitopes Bound by the Major Histocompatibility Complex Class I Molecule Mamu-A*01: Implications for Vaccine Design and Testing
TM Allen, BR Mothé, J Sidney, P Jing, JL Dzuris, ME Liebl, TU Vogel, DH O'Connor, X Wang, MC Wussow, JA Thomson, JD Altman, DI Watkins, A Sette
Journal of virology 2001
Immunopathogenesis of HIV-1 infection
H Cao, BD Walker
Clinics in Dermatology 2000
HIV-1-specific cellular immune responses among HIV-1-resistant sex workers
KR Fowke, R Kaul, KL Rosenthal, J Oyugi, J Kimani, WJ Rutherford, NJ Nagelkerke, TB Ball, JJ Bwayo, JN Simonsen, GM Shearer, FA Plummer
Immunology and Cell Biology 2000
Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection
D Bienzle, KS Macdonald, KF Copeland, JJ Bwayo, FA Plummer, KL Rosenthal
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 2000
Human memory CTL response specific for influenza A virus is broad and multispecific
C Gianfrani, C Oseroff, J Sidney, RW Chesnut, A Sette
Human Immunology 2000
Temporal Loss of Nef-Epitope CTL Recognition following Macaque Lipopeptide Immunization and SIV Challenge
L Mortara, F Letourneur, P Villefroy, C Beyer, H Gras-Masse, JG Guillet, I Bourgault-Villada
Virology 2000
Biomedical Research Reports
JY Lau, DN Standring
Biomedical Research Reports 2000
Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes and Protection Against Challenge in Rhesus Macaques Immunized with a Live Attenuated Simian Immunodeficiency Virus Vaccine
DF Nixon, SM Donahoe, WM Kakimoto, RV Samuel, KJ Metzner, A Gettie, T Hanke, PA Marx, RI Connor
Virology 2000
Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL
IM Belyakov, JD Ahlers, JD Clements, W Strober, JA Berzofsky
Journal of immunology (Baltimore, Md. : 1950) 2000
Intranasal Immunization with HIV Reverse Transcriptase: Effect of Dose in the Induction of Helper T Cell Type 1 and 2 Immunity
SE Pacheco, RA Gibbs, A Ansari-Lari, P Rogers
AIDS Research and Human Retroviruses 2000
Live Attenuated HIV Vaccines: A Proposal for Further Research and Development
J Mills, R Desrosiers, E Rud, N Almond
AIDS Research and Human Retroviruses 2000
Identification of Highly Conserved and Broadly Cross-Reactive HIV Type 1 Cytotoxic T Lymphocyte Epitopes as Candidate Immunogens for Inclusion in Mycobacterium bovis BCG-Vectored HIV Vaccines
G Ferrari, DD Kostyu, J Cox, DV Dawson, J Flores, KJ Weinhold, S Osmanov
AIDS Research and Human Retroviruses 2000
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
N Meidenbauer, DT Harris, LE Spitler, TL Whiteside
The Prostate 2000
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia:
L Dorrell, AJ Hessell, M Wang, H Whittle, S Sabally, S Rowland-Jones, DR Burton, PW Parren
AIDS 2000
Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications
CS Cruz, R Tan, SL Rowland-Jones, BH Barber
International Immunology 2000
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
T Hanke, AJ McMichael
Nature Medicine 2000
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4 + T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T Lymphocytes
ME Severino, NV Sipsas, PT Nguyen, SA Kalams, BD Walker, RP Johnson, OO Yang
Journal of virology 2000
Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide
MM Gherardi, JC Ramírez, M Esteban
Journal of virology 2000
HIV-1-Specific Mucosal CD8 + Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
R Kaul, FA Plummer, J Kimani, T Dong, P Kiama, T Rostron, E Njagi, KS MacDonald, JJ Bwayo, AJ McMichael, SL Rowland-Jones
Journal of immunology (Baltimore, Md. : 1950) 2000
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
R Kaul, D Trabattoni, JJ Bwayo, D Arienti, A Zagliani, FM Mwangi, C Kariuki, EN Ngugi, KS MacDonald, TB Ball, M Clerici, FA Plummer
AIDS 1999
Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa
L Dorrell, T Dong, GS Ogg, S Lister, S McAdam, T Rostron, C Conlon, AJ McMichael, SL Rowland-Jones
Journal of virology 1999
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
T Hanke, RV Samuel, TJ Blanchard, VC Neumann, TM Allen, JE Boyson, SA Sharpe, N Cook, GL Smith, DI Watkins, MP Cranage, AJ McMichael
Journal of virology 1999
T lymphocyte responses in HIV-1 infection: implications for vaccine development
C Brander, BD Walker
Current Opinion in Immunology 1999
Use of Herpesvirus saimiri-immortalized macaque CD4+ T cell clones as stimulators and targets for assessment of CTL responses in macaque/AIDS models
A Kumar, HL Stipp, D Sheffer, O Narayan
Journal of Immunological Methods 1999
Frequency of CD8+ T Lymphocytes Specific for Lytic and Latent Antigens of Epstein–Barr Virus in Healthy Virus Carriers
G Benninger-Döring, S Pepperl, L Deml, S Modrow, H Wolf, W Jilg
Virology 1999
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
M Girard, A Habel, C Chanel
Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie 1999
Immune correlates of protection from HIV and AIDS – more answers but yet more questions
JL Heeney, P Beverley, A McMichael, G Shearer, J Strominger, B Wahren, J Weber, F Gotch
Immunology Today 1999
Is an HIV vaccine possible?
AJ McMichael, T Hanke
Nature Medicine 1999
HIV-Infekt
NH Brockmeyer, L Mertins
1997
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994

← Previous 1 2 3 … 12 13 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 1 X users
Referenced in 7 patents
97 readers on Mendeley
1 readers on CiteULike
See more details